These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Structure-activity relationship studies of PACAP-27 and VIP analogues. Kashimoto K; Nagano Y; Suitani Y; Hamanaka K; Mizumoto T; Tomizaki K; Takahata H; Nagamoto A; Ohata A; Yoshihara S; Ichimura T Ann N Y Acad Sci; 1996 Dec; 805():505-10. PubMed ID: 8993431 [No Abstract] [Full Text] [Related]
5. The effect of the vasoactive intestinal polypeptide agonist Ro 25-1553 on induced tone in isolated human airways and pulmonary artery. Schmidt DT; Rühlmann E; Waldeck B; Branscheid D; Luts A; Sundler F; Rabe KF Naunyn Schmiedebergs Arch Pharmacol; 2001 Oct; 364(4):314-20. PubMed ID: 11683518 [TBL] [Abstract][Full Text] [Related]
6. [Experimental study of the effects of pituitary adenylate cyclase-activating polypeptide (PACAP) and its mechanism on the vascular cell components--the possible relationship between PACAP and atherosclerosis]. Chang Q Sheng Li Ke Xue Jin Zhan; 1997 Apr; 28(2):132-5. PubMed ID: 11038706 [TBL] [Abstract][Full Text] [Related]
7. Role of Na(+)-K(+)-ATPase in airway smooth muscle relaxation by vasoactive intestinal peptide and pituitary adenylate cyclase activating peptide. Kanemura T; Tamaoki J; Chiyotani A; Takeyama K; Sakai N; Tagaya E; Konno K Res Commun Chem Pathol Pharmacol; 1993 Jan; 79(1):11-22. PubMed ID: 8381977 [TBL] [Abstract][Full Text] [Related]
8. Basic aspects of vasorelaxant and bronchodilating peptides in clinical use: urodilatin (INN: Ularitide), VIP, and PACAP. Meyer M; Flüge T; Kruhøffer M; Forssmann WG Ann N Y Acad Sci; 1996 Dec; 805():443-61; discussion 461-3. PubMed ID: 8993423 [No Abstract] [Full Text] [Related]
9. Structure-activity studies on VIP: IV. The synthetic agonist helodermin-fragment-(1-28)-amide is a potent VIP-agonist with prolonged duration of tracheal relaxant activity. Jaeger E; Bauer S; Joyce MW; Foda HD; Berisha HI; Said SI Ann N Y Acad Sci; 1996 Dec; 805():499-504. PubMed ID: 8993430 [No Abstract] [Full Text] [Related]
10. Role of PACAP in the female reproductive organs. Fahrenkrug J; Steenstrup BR; Hannibal J; Alm P; Ottesen B Ann N Y Acad Sci; 1996 Dec; 805():394-407; discussion 407-9. PubMed ID: 8993420 [No Abstract] [Full Text] [Related]
11. Helospectin, induces a potent relaxation of human airways in vitro. Cardell M; Cardell LO Peptides; 2001 Sep; 22(9):1359-62. PubMed ID: 11514015 [TBL] [Abstract][Full Text] [Related]
12. [Comparative study of the relaxation mechanism in the smooth muscles of bronchi and pulmonary artery in rat]. Leont'eva GR; Leont'ev VG; Krivchenko AI Zh Evol Biokhim Fiziol; 2002; 38(6):599-607. PubMed ID: 12625064 [No Abstract] [Full Text] [Related]
13. The induction of nitric oxide-mediated relaxation of human isolated pulmonary arteries by PACAP. Cardell LO; Hjert O; Uddman R Br J Pharmacol; 1997 Mar; 120(6):1096-100. PubMed ID: 9134222 [TBL] [Abstract][Full Text] [Related]
17. The P(2)-purinoceptor antagonist suramin is a competitive antagonist at vasoactive intestinal peptide receptors in the rat gastric fundus. Jenkinson KM; Reid JJ Br J Pharmacol; 2000 Aug; 130(7):1632-8. PubMed ID: 10928968 [TBL] [Abstract][Full Text] [Related]
18. Control of airway smooth muscle tone: II-pharmacology of relaxation. Thirstrup S Respir Med; 2000 Jun; 94(6):519-28. PubMed ID: 10921754 [No Abstract] [Full Text] [Related]
19. PACAP inhibits spontaneous contractions in the intestine of the Atlantic cod, Gadus morhua. Olsson C; Holmgren S Ann N Y Acad Sci; 1998 Dec; 865():512-4. PubMed ID: 10026090 [No Abstract] [Full Text] [Related]
20. Alfa 1 adrenergic potentiation of progesterone accumulation stimulated by vasoactive intestinal peptide (VIP) and pituitary adenylate cyclase-activating polypeptide (PACAP) in cultured rat granulosa cells. Wasilewska-Dziubiñska E; Borowiec M; Chmielowska M; Woliñska-Witort E; Baranowska B Neuro Endocrinol Lett; 2002 Apr; 23(2):141-8. PubMed ID: 12011800 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]